Our portfolio companies aim to develop interventions that can significantly improve quality of life today by targeting the features of aging.
Aeovian Pharmaceuticals is a San Francisco Bay Area-based R&D-stage biopharmaceutical company developing novel and highly selective therapeutics modulating the mTORC1 pathway.
view website
Cleara Biotech is a preclinical R&D company engaged in the creation of therapeutics targeting cellular senescence by designing novel compounds that selectively eliminate senescent cells.
view website
Samsara Therapeutics is a drug discovery and development platform focused on identification, chemical optimization, and in vivo validation of new compounds that extend healthy lifespan.
view websiteWe are looking forward to hearing from you about opportunities to collaborate and share more information about our work.